Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

High drug prices demand serious solutions. While tariffs aim to address these issues head-on, they may not deliver the ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but the ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

"We've cut drug prices by 1,200, 1,300, 1,400, 1,500 percent. I don't mean 50 percent. I mean 14-, 1,500 percent," Trump said ...

Our system provides the best of both worlds: development of new drugs and cheap options for most prescriptions. | Opinion ...

Trump signed an Executive Order May 12 directing the administration to take action to bring drug prices charged in the U.S.

Little-known provisions lobbied by industry will cost Medicare billions in missed savings.

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.